Related references
Note: Only part of the references are listed.The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial
A. Rafnsson et al.
DIABETOLOGIA (2012)
Endothelial Endothelin B Receptor-Mediated Prevention of Cerebrovascular Remodeling Is Attenuated in Diabetes Because of Up-Regulation of Smooth Muscle Endothelin Receptors
Aisha I. Kelly-Cobbs et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Arginase II Deletion Increases Corpora Cavernosa Relaxation in Diabetic Mice
Haroldo A. Toque et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes
Kamakshi Sachidanandam et al.
DIABETES (2007)
Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis - Role of endothelin-1
AK Harris et al.
DIABETES (2005)
Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery
T Matsumoto et al.
PEPTIDES (2004)
Endothelin-1-induced impairment of endothelium-dependent relaxation in aortas isolated from controls and diabetic rats
K Kamata et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction
F Amiri et al.
CIRCULATION (2004)
Reactive oxygen species in vascular biology: implications in hypertension
RM Touyz et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Vascular structural and functional changes in type 2 diabetes mellitus - Evidence for the roles of abnormal myogenic responsiveness and dyslipidemia
I Schofield et al.
CIRCULATION (2002)
Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat
N Kanie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes
RE Gilbert et al.
CIRCULATION RESEARCH (2000)
Share Paper
